1. Introduction {#sec1-ijerph-17-04962}
===============

Hemiplegic shoulder pain (HSP) is a common and disabling complication following a stroke, and it may affect the quality of life \[[@B1-ijerph-17-04962]\]. It often occurs following two to three months of stroke \[[@B2-ijerph-17-04962],[@B3-ijerph-17-04962]\]. Consequently, HSP may result in withdrawal from rehabilitation programs, longer hospital stays, reduced limb movement, and impaired quality of life \[[@B1-ijerph-17-04962]\]. Numerous causes have been implicated in developing HSP in stroke. This includes muscle flaccidity around the shoulder joint, shoulder subluxation, shoulder-hand syndrome, increased muscle tone, impingement syndrome, frozen shoulder, brachial plexus injury, and the thalamic syndrome \[[@B4-ijerph-17-04962],[@B5-ijerph-17-04962]\].

There is an inconsistency in reporting incidence and prevalence of HSP following stroke. Some studies reported that the incidence of HSP ranges from 16% to 84% \[[@B6-ijerph-17-04962],[@B7-ijerph-17-04962]\], while others reported a range of 65% to 70% \[[@B8-ijerph-17-04962],[@B9-ijerph-17-04962]\]. In other studies, the incidence rate was ranging from 24% to 64% in those stroke populations who are admitted to an inpatient rehabilitation unit \[[@B10-ijerph-17-04962],[@B11-ijerph-17-04962],[@B12-ijerph-17-04962],[@B13-ijerph-17-04962]\] and it varied from 9% to 40% in those who are not admitted \[[@B14-ijerph-17-04962],[@B15-ijerph-17-04962],[@B16-ijerph-17-04962]\].

A reduced arm motor function at the time of stroke or over a period during rehabilitation was found to be one of the risk factors for developing HSP following stroke \[[@B6-ijerph-17-04962],[@B10-ijerph-17-04962]\]. Additionally, HSP often occurs and tends to be more severe among people with left-sided hemiplegia \[[@B15-ijerph-17-04962],[@B17-ijerph-17-04962],[@B18-ijerph-17-04962]\]. Reduced shoulder motion in the affected side of persons with HSP is presented in the initial weeks following stroke \[[@B19-ijerph-17-04962]\] and it gradually worsens after one month \[[@B19-ijerph-17-04962],[@B20-ijerph-17-04962],[@B21-ijerph-17-04962]\]. Other factors probably causing HSP can include shoulder subluxation \[[@B22-ijerph-17-04962]\] or rotator cuff injury \[[@B23-ijerph-17-04962]\], and those which are related to the neurological problem such as impaired sensation, hemispatial neglect, spasticity, and flaccid paralysis \[[@B24-ijerph-17-04962],[@B25-ijerph-17-04962]\].

Despite many observational and interventional studies, incidence, prevalence, and the clinical presentations of HSP differ and the exact underlying factors causing HSP are unknown, resulting lack of knowledge in designing effective strategies to prevent and treat HSP. Currently, there were no studies systematically explored the incidence, prevalence, and the risk factors causing shoulder pain in patients with stroke. Therefore, the current systematic review aimed to investigate the incidence, prevalence, and risk factors causing HSP after stroke.

2. Materials and Methods {#sec2-ijerph-17-04962}
========================

This systematic review followed the guideline for the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) \[[@B26-ijerph-17-04962]\]. This systematic review was prospectively registered in PROSPERO (CRD42017077594) and available at <http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017077594>.

2.1. Search Strategy {#sec2dot1-ijerph-17-04962}
--------------------

The electronic databases PubMed, Web of Science, and Scopus were searched until November 19, 2019. Additionally, potential articles were searched manually from the reference list given in each article. The literature search in PubMed was conducted using the following keywords: ("Stroke" OR "Hemiplegia") AND ("Shoulder" OR "Arm" OR "Shoulder joint") AND ("Shoulder pain" OR "Pain") AND ("Prevalence" OR "Incidence") \[[Table 1](#ijerph-17-04962-t001){ref-type="table"}\].

2.2. Eligibility Criteria {#sec2dot2-ijerph-17-04962}
-------------------------

The current review included all the published literature that qualified the following criteria: studies included adults over 18 years of age with a history of stroke for more than one month; the outcomes of included studies should be pain in and around shoulder excluding ribs and the neck pain; all cross-sectional and longitudinal studies to assess the natural course of events after stroke and; studies describing potential risk factors such as demographic factors or impairments related to post-stroke shoulder pain that was evaluated after the incidence of stroke.

Studies were excluded if they were not published in English. Additionally, case reports and case series were also excluded as these types of studies might have a high potential bias. Furthermore, if the cause of shoulder pain was not secondary to stroke, those studies were also excluded (for instance, shoulder pain due to neck pathology).

2.3. Study Selection {#sec2dot3-ijerph-17-04962}
--------------------

Two independent authors screened titles and abstract for the eligibility of the included studies. Studies, which reported the incidence, prevalence, and risk factors of HPS following stroke were included. Any disagreements between two reviewers in the study selection were discussed and resolved by consensus between them.

2.4. Data Extraction and Assessment of the Risk of Bias {#sec2dot4-ijerph-17-04962}
-------------------------------------------------------

Two independent authors (SA and AA) completed the data extraction and assessment of the risk of bias, using structured formats. The important data extraction included the following items: author's name, setting, country of origin, sample size, target population, time since stroke (months), the average age of patients, outcome measurement, and study design. Quality assessment and risk of bias in the selected studies were appraised using the Newcastle-Ottawa Scale for evaluating the quality of nonrandomized studies in meta-analyses \[[@B27-ijerph-17-04962],[@B28-ijerph-17-04962]\]. This evaluation tool has considered three factors (e.g., selection of exposed and non-exposed cohort, comparability of cohorts based on the design or analysis, and outcome based on reliability and validity of the scale, adequate follow-up and dropout rate) to appraise the quality of each included study \[[@B27-ijerph-17-04962],[@B28-ijerph-17-04962]\]. The quality of each study was rated as good, fair, and poor by assigning stars in each domain as per given the guidelines of the Newcastle-Ottawa Scale \[[@B27-ijerph-17-04962],[@B28-ijerph-17-04962]\]. A "good" quality score was given if the included study received 3 or 4 stars in selection domain,1 or 2 stars in comparability domain, and 2 or 3 stars in outcome domain. A "fair" quality score was given if the included study received 2 stars in selection domain,1 or 2 stars in comparability domain, and 2 or 3 stars in outcome domain. A "poor" quality score indicated 0 or 1 star(s) in selection domain, or 0 stars in comparability domain, or 0 or 1 star(s) in outcome domain ([Table 2](#ijerph-17-04962-t002){ref-type="table"}). Any disagreements between two reviewers were discussed and resolved by consensus between them.

2.5. Summary Statistics and Synthesis of Results {#sec2dot5-ijerph-17-04962}
------------------------------------------------

Incidence and prevalence of HSP were reported from the included studies. Prevalence of HSP in the defined group was also reported if the information is available in the included studies. Most significant predictors of HSP after stroke were determined from the included studies. The Comprehensive Meta-Analysis software was used to conduct a meta-analysis. Meta-analysis was conducted for the prevalence, incidence, and risk factors of shoulder pain after stroke if at least two or more included studies with the adequate data for the analysis were available. The event rates for the prevalence and incidence estimates and the odd ratios (ORs) for the risk factors of shoulder pain after stroke were calculated. The effect size with 95% confidence intervals (CIs) for the prevalence, incidence, and risk factors of shoulder pain after stroke were calculated.

3. Results {#sec3-ijerph-17-04962}
==========

3.1. Study Selection {#sec3dot1-ijerph-17-04962}
--------------------

Based on the abstract and title search, initially, 390 articles were identified. After excluding duplicates (*N* = 251) and screening of abstracts, a total of 330 studies were not relevant to the current review, therefore excluded. Sixty full-text articles were included in the final screening, of which 42 articles failed to match the inclusion criteria, and were hence excluded. Henceforth, a total of 18 studies included in the final synthesis \[[@B3-ijerph-17-04962],[@B6-ijerph-17-04962],[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B28-ijerph-17-04962],[@B29-ijerph-17-04962],[@B30-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B33-ijerph-17-04962],[@B34-ijerph-17-04962],[@B35-ijerph-17-04962],[@B36-ijerph-17-04962],[@B37-ijerph-17-04962],[@B38-ijerph-17-04962],[@B39-ijerph-17-04962]\]. [Figure 1](#ijerph-17-04962-f001){ref-type="fig"} shows the details of the study selection process and results of the literature search \[[@B26-ijerph-17-04962]\].

3.2. Characteristics of Included Studies {#sec3dot2-ijerph-17-04962}
----------------------------------------

[Table 3](#ijerph-17-04962-t003){ref-type="table"} present the characteristics of included studies. Among 18 included studies \[[@B3-ijerph-17-04962],[@B6-ijerph-17-04962],[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B29-ijerph-17-04962],[@B30-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B33-ijerph-17-04962],[@B34-ijerph-17-04962],[@B35-ijerph-17-04962],[@B36-ijerph-17-04962],[@B37-ijerph-17-04962],[@B38-ijerph-17-04962],[@B39-ijerph-17-04962],[@B40-ijerph-17-04962]\], sixteen were categorized as a prospective observational study \[[@B3-ijerph-17-04962],[@B6-ijerph-17-04962],[@B9-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B29-ijerph-17-04962],[@B30-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B33-ijerph-17-04962],[@B34-ijerph-17-04962],[@B35-ijerph-17-04962],[@B37-ijerph-17-04962],[@B38-ijerph-17-04962],[@B39-ijerph-17-04962],[@B40-ijerph-17-04962]\], while others as a retrospective observational study \[[@B11-ijerph-17-04962],[@B36-ijerph-17-04962]\]. Studies originated from the UK \[[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B29-ijerph-17-04962],[@B30-ijerph-17-04962]\], Turkey \[[@B9-ijerph-17-04962],[@B39-ijerph-17-04962]\], Sweden \[[@B6-ijerph-17-04962],[@B34-ijerph-17-04962]\], Thailand \[[@B31-ijerph-17-04962],[@B35-ijerph-17-04962]\], Australia \[[@B3-ijerph-17-04962],[@B11-ijerph-17-04962]\], Denmark \[[@B32-ijerph-17-04962],[@B33-ijerph-17-04962]\], Taiwan \[[@B36-ijerph-17-04962]\], Korea \[[@B37-ijerph-17-04962],[@B38-ijerph-17-04962]\], and Italy \[[@B40-ijerph-17-04962]\]. In all studies, the number of patients ranged between 58 and 608 with the mean age ranging from 58.7 to 76 years. Four included studies have defined participants as first-ever stroke patients \[[@B6-ijerph-17-04962],[@B34-ijerph-17-04962],[@B36-ijerph-17-04962],[@B37-ijerph-17-04962]\]. Most of the other studies have defined participants as patients with stroke \[[@B3-ijerph-17-04962],[@B11-ijerph-17-04962],[@B14-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B33-ijerph-17-04962],[@B35-ijerph-17-04962],[@B38-ijerph-17-04962],[@B39-ijerph-17-04962],[@B40-ijerph-17-04962]\], while two studies \[[@B16-ijerph-17-04962],[@B29-ijerph-17-04962]\] have defined participants as patients with a diagnosis of acute stroke. In all studies, the time since incidence of a stroke at recruitment was within one week of symptom onset up to 30 months after stroke. Seven include studies used a visual analog scale (VAS) \[[@B3-ijerph-17-04962],[@B6-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B29-ijerph-17-04962],[@B30-ijerph-17-04962],[@B34-ijerph-17-04962]\], two studies used a numerical rating scale (NRS) \[[@B32-ijerph-17-04962],[@B37-ijerph-17-04962]\], one study used a Neuropathic Pain Symptom Inventory \[[@B40-ijerph-17-04962]\], one study used the University of Alabama's Pain Behaviors Scale \[[@B38-ijerph-17-04962]\], one study used medical records \[[@B36-ijerph-17-04962]\], and one study used an interview method \[[@B33-ijerph-17-04962]\], while others used physical examination to assess shoulder pain after stroke \[[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B31-ijerph-17-04962],[@B35-ijerph-17-04962],[@B39-ijerph-17-04962]\].

3.3. Methodological Quality {#sec3dot3-ijerph-17-04962}
---------------------------

[Table 2](#ijerph-17-04962-t002){ref-type="table"} presented the results of the quality assessment using the Newcastle--Ottawa Scale for evaluating the quality of nonrandomized studies in meta-analyses \[[@B27-ijerph-17-04962],[@B28-ijerph-17-04962]\]. Seven included studies \[[@B3-ijerph-17-04962],[@B6-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B34-ijerph-17-04962],[@B35-ijerph-17-04962],[@B37-ijerph-17-04962]\] were rated as "good "quality, while one study \[[@B39-ijerph-17-04962]\] rated "fair" and 10 studies \[[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B29-ijerph-17-04962],[@B30-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B33-ijerph-17-04962],[@B36-ijerph-17-04962],[@B38-ijerph-17-04962],[@B40-ijerph-17-04962]\] rated "poor" quality. Five included studies \[[@B14-ijerph-17-04962],[@B30-ijerph-17-04962],[@B33-ijerph-17-04962],[@B36-ijerph-17-04962],[@B40-ijerph-17-04962]\] did not have any non-exposed control group. More than half of the included studies \[[@B3-ijerph-17-04962],[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B31-ijerph-17-04962],[@B33-ijerph-17-04962],[@B35-ijerph-17-04962],[@B36-ijerph-17-04962],[@B38-ijerph-17-04962],[@B39-ijerph-17-04962],[@B40-ijerph-17-04962]\] had reported the presence of outcome at the start of the study. Eight included studies \[[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B29-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B36-ijerph-17-04962],[@B38-ijerph-17-04962],[@B40-ijerph-17-04962]\] reported less than 6-month of follow-up. Nine included studies \[[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B29-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B36-ijerph-17-04962],[@B38-ijerph-17-04962],[@B39-ijerph-17-04962],[@B40-ijerph-17-04962]\] did not provide information about the dropouts.

3.4. Incidence and Prevalence of HSP after Stroke {#sec3dot4-ijerph-17-04962}
-------------------------------------------------

The details of the incidence and prevalence of HSP after stroke is given in [Table 4](#ijerph-17-04962-t004){ref-type="table"}. The overall incidence of HSP was ranging from 1.6 to 40% in the included studies. The overall prevalence of HSP was ranging from 9.41 to 91.9% in the included studies. The incidence of HSP after a stroke at admission was reported in two studies \[[@B3-ijerph-17-04962],[@B14-ijerph-17-04962]\]. Incidence at admission ranged from 9 to 10%. Three studies reported on the prevalence of HSP after a stroke at admission \[[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B39-ijerph-17-04962]\], ranging from 23 to 63.5%. The incidence of HSP after a stroke at 6 months was reported in three studies \[[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B33-ijerph-17-04962]\], ranging from 15 to 40%. Only one study reported the 6-month prevalence (42%) of HSP after a stroke \[[@B30-ijerph-17-04962]\]. Only one study reported the 12-month incidence (21%) of HSP after stroke \[[@B3-ijerph-17-04962]\]. Two studies reported the 12-month prevalence of HSP after stroke \[[@B30-ijerph-17-04962],[@B35-ijerph-17-04962]\], ranging from 8.5 to 47%. Only one study reported the two-year incidence (15.1%) of HSP after a stroke \[[@B32-ijerph-17-04962]\].

3.5. Risk Factors of HSP after Stroke {#sec3dot5-ijerph-17-04962}
-------------------------------------

[Table 5](#ijerph-17-04962-t005){ref-type="table"} presented the risk factors of HSP used in the included studies. A variety of risk factors was assessed in the included studies \[[@B3-ijerph-17-04962],[@B6-ijerph-17-04962],[@B9-ijerph-17-04962],[@B11-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B29-ijerph-17-04962],[@B31-ijerph-17-04962],[@B32-ijerph-17-04962],[@B34-ijerph-17-04962],[@B37-ijerph-17-04962],[@B39-ijerph-17-04962]\]. The most significant risk factors of HSP were age, arm weakness, sensory impairment, abnormal shoulder joint examination, average depression score, functional status, self-perceived ill health, subluxation, pathogenesis, left-sided hemiparesis, and prior history of shoulder pain. Six studies did not assess the risk factors of HSP after stroke \[[@B30-ijerph-17-04962],[@B33-ijerph-17-04962],[@B35-ijerph-17-04962],[@B36-ijerph-17-04962],[@B38-ijerph-17-04962],[@B40-ijerph-17-04962]\].

3.6. Meta-Analysis {#sec3dot6-ijerph-17-04962}
------------------

Of the 10 included studies with adequate prevalence data, three estimated event rates for the prevalence at admission, two estimated event rates for the prevalence at 4-month, 12-month, and 16-month, while four estimated event rates for an overall prevalence of shoulder pain after stroke. [Figure 2](#ijerph-17-04962-f002){ref-type="fig"} indicates a forest plot of prevalence rates with effect sizes and 95% CIs. Of the five included studies with adequate incidence data, two estimated event rates of the incidence at admission, while three estimated event rates of incidence at 6-month of shoulder pain after stroke. [Figure 3](#ijerph-17-04962-f003){ref-type="fig"} indicates a forest plot of incidence rates with effect sizes and 95% CIs. Of the eight included studies with adequate risk estimate data, three studies estimated ORs stratified by gender, two stratified by tone, sensation, affected body side, hemispatial neglect, and National Institutes of Health Stroke Scale Score, while three stratified based on type of strokes and seven stratified based on past medical history. [Figure 4](#ijerph-17-04962-f004){ref-type="fig"} and [Figure 5](#ijerph-17-04962-f005){ref-type="fig"} indicate a forest plot of risk factors with effect sizes and 95% CIs.

4. Discussion {#sec4-ijerph-17-04962}
=============

Many reviews on HSP have been published in recent decades \[[@B41-ijerph-17-04962],[@B42-ijerph-17-04962],[@B43-ijerph-17-04962],[@B44-ijerph-17-04962],[@B45-ijerph-17-04962],[@B46-ijerph-17-04962]\]. However, these reviews focus on the cause and treatment of HSP after stroke. As per our knowledge, this is the first systematic review, presenting the results of 18 studies on the incidence and prevalence of HSP after stroke. Additionally, the present review assessed the risk factors causing HSP after stroke. In the current review, a total of 5086 patients with a mean age ranging from 58.7 to 76 years were included. Seven included studies were rated as "good" quality, while one study rated "fair", and 10 studies rated "poor" quality. Eleven studies reported the prevalence, while eight studies reported the incidence rate of HSP following a stroke. The incidence of HSP was ranging from 10 to 22% in the metanalysis of the included studies. The prevalence of HSP was ranging from 22 to 47% in the metanalysis of the included studies.

Previous studies reported the prevalence of shoulder pain after stroke between 21% and 84% \[[@B6-ijerph-17-04962],[@B12-ijerph-17-04962],[@B14-ijerph-17-04962],[@B16-ijerph-17-04962],[@B30-ijerph-17-04962]\], while others reported 5% and 84% \[[@B47-ijerph-17-04962],[@B48-ijerph-17-04962]\]. The wide variation in the prevalence of HSP reflects the lack of proper definition or an inconsistency in the quality of care of these patients among diverse populations \[[@B49-ijerph-17-04962],[@B50-ijerph-17-04962]\]. Incidence at admission was approximately 10% in the present review. The incidence of HSP after a stroke at 6 months was 22% in the present review. Wanklyn et al. \[[@B51-ijerph-17-04962]\] reported that about 63% of the patients developed HSP in the first six months after stroke. Other studies reported that the HSP usually develops within 2--3 months following the stroke onset \[[@B2-ijerph-17-04962],[@B6-ijerph-17-04962],[@B16-ijerph-17-04962]\]. In the current review, 12 months prevalence of HSP after a stroke was 39%. A previous study reported the prevalence of HSP about 32% within the 12 months after a stroke \[[@B52-ijerph-17-04962]\]. Another study reported the prevalence of HSP about 34% at 12 months after a stroke \[[@B36-ijerph-17-04962]\].

In the current review, the most significant identified predictors of HSP were age (younger than 70 years), female gender, increased tone, sensory impairment, left-sided hemiparesis, hemorrhagic stroke, hemispatial neglect, positive past medical history, and poor National Institutes of Health Stroke Scale score. In the previous study, age was not directly linked to the development of HSP, but older people could have preexisting problems that affect shoulder pain \[[@B53-ijerph-17-04962]\]. Another study reported various risk factors, including impaired motor control, reduced proprioception, sensory impairment, spasticity of the elbow flexor muscles, limited range of motion (ROM) of the shoulder joint, and type 2 diabetes mellitus \[[@B54-ijerph-17-04962]\]. Barlak et al. \[[@B13-ijerph-17-04962]\] reported a significant correlation between HSP and complex regional pain syndrome and adhesive capsulitis, but there was no correlation found between the HSP and the grade of subluxation, impingement syndrome or spasticity. Similarly, other studies also reported many risk factors for shoulder pain, and the severity of motor impairment is one of the most important risk factors identified \[[@B6-ijerph-17-04962],[@B15-ijerph-17-04962],[@B16-ijerph-17-04962],[@B40-ijerph-17-04962],[@B51-ijerph-17-04962],[@B54-ijerph-17-04962]\].

During the recovery from stroke, muscle spasticity of the upper extremities is thought to cause shoulder subluxation and limited ROM, resulting in the development of shoulder pain \[[@B55-ijerph-17-04962]\]. Another important cause of HSP is frozen shoulder (Adhesive capsulitis), which is indicated by a limited shoulder ROM, with a capsular type of restriction \[[@B56-ijerph-17-04962],[@B57-ijerph-17-04962],[@B58-ijerph-17-04962]\]. However, other factors could also cause a reduced shoulder ROM in stroke patients without frozen shoulder. Mao et al. \[[@B59-ijerph-17-04962]\] identified a prolonged, shortened position was one of the causes of developing soft tissues contracture around the shoulder such as muscles, tendons, and ligaments. The current review was not able to identify a single pathology causing shoulder pain in patients with stroke. This area of research should be explored in the future investigations.

The major strength of this review was the inclusion of a metanalysis, which identified many risk factors causing shoulder pain after stroke. Additionally, most of the included studies were categorized as a prospective observational study, which further enhances the validity of the results. The present study had some potential limitations as well. Some of the included studies did not use a valid and reliable outcome measure to assess symptoms of shoulder pain, which could affect the validity of the results. Additionally, most of the included studies did not report the exact cause of shoulder pain following stroke. Furthermore, variations in the participants' characteristics in the included studies prevent to make any causal relationships between shoulder pain and predictor measures.

5. Conclusions {#sec5-ijerph-17-04962}
==============

The incidence and prevalence of shoulder pain after stroke vary considerably due to various factors. Knowledge of predictors is important to minimize the risk of developing shoulder pain following a stroke.
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ijerph-17-04962-t001_Table 1

###### 

Search Strategy.

                                            PubMed        Web of Science   Scopus
  ----------------------------------------- ------------- ---------------- -------------
  Date                                      19-Nov-2019   19-Nov-2019      19-Nov-2019
  "Stroke" OR "Hemiplegia"                  291,950       296,060          395,489
  "Shoulder" OR "Arm" OR "Shoulder joint"   213,412       228,005          450,679
  "Shoulder pain" OR "Pain"                 678,816       538,019          1,038,105
  "Prevalence" OR "Incidence"               1,323,666     1,288,045        1,882,741
  Combined search                           94            115              181
  Total minus duplicates                    139                            

ijerph-17-04962-t002_Table 2

###### 

Results of the quality assessment using the Newcastle-Ottawa Quality Assessment Scale criteria.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Studies                                                    Selection                                                                                                                                                                                                   Comparability                         Outcome                                                  Quality Score †                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ---------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------- -------------------------------------------------------- ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------- -------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------- ------
                                                             Representativeness of the exposed cohort                                                                                                                                                                    Selection of the non-exposed cohort   Ascertainment of exposure                                Outcome of Interest Was Not Present at\   Comparability of cohorts based on the design or analysis                                                                                                                                   Assessment of outcome                        Follow-Up Long Enough for Outcome to Occur (Median Duration of Follow-Up ≥ 6 Months)   Adequacy of follow up of cohorts                                                                                
                                                                                                                                                                                                                                                                                                                                                                        Start of Study                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Langhorne et al. (2000) \[[@B14-ijerph-17-04962]\]         Three major hospitals in the West of Scotland were participated. Two hospitals provided acute stroke patient care and one hospital provide acute stroke rehabilitation care after one-week discharge. ★     No non-exposed cohort                 Weekly assessments in hospitals by 3 research nurses ★   Yes ★                                     Complication subdivided by their baseline level of dependency and compared using Chi-square test. ★                                                                                        Questionnaire based structured interview ★   Yes ★                                                                                  100% participated at the 6-month follow-up, 99% at the 18-month follow-up, and 93% at the 30-month. ★           Good

  Gamble et al. (2000) \[[@B29-ijerph-17-04962]\]            Consecutive cohort of stroke patients admitted to a single hospital.                                                                                                                                        Yes ★                                 Patients underwent interview about shoulder pain ★       Yes ★                                     Age, sex, level of anxiety, disability score, or moderate to severe motor weakness were adjusted in chi-square test. ★                                                                     Questionnaire based structured interview ★   No                                                                                     Not reported                                                                                                    Poor

  Gamble et al. (2002) \[[@B16-ijerph-17-04962]\]            Consecutive cohort of stroke patients admitted to a single hospital.                                                                                                                                        Yes ★                                 Patients underwent interview about shoulder pain ★       Yes ★                                     Age, sex, depression and anxiety scores, and functional scores were adjusted in chi-square test. ★                                                                                         Questionnaire based structured interview ★   Yes ★                                                                                  97% participated at the 6-month follow-up. ★                                                                    Good

  Aras et al. (2004) \[[@B9-ijerph-17-04962]\]               Consecutive cohort of stroke\                                                                                                                                                                               Yes ★                                 Patients underwent interview about\                      No                                        The presence of spasticity, thalamic pain, neglect, and comorbidities were compared between groups with and without shoulder pain. ★                                                       Questionnaire based structured interview ★   No                                                                                     No statement                                                                                                    Poor
                                                             patients admitted to a single hospital.                                                                                                                                                                                                           shoulder pain ★                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Lindgren et al. (2007) \[[@B6-ijerph-17-04962]\]           Participants were representative of the Lund Stroke Register which covers the population of Lund-Orup, including 8 municipalities representing the local geographical area of Lund University Hospital. ★   Yes ★                                 Patients underwent interview about shoulder pain ★       Yes ★                                     Univariate analyses were used to compare arm motor function, disability, self-perceived health, subluxation, and sensory disturbance, between patients with and without shoulder pain. ★   Questionnaire based structured interview ★   Yes ★                                                                                  79% participated at the 4-month follow-up, and 73% at the 12-month follow-up. ★                                 Good

  Sackley et al. (2008) \[[@B30-ijerph-17-04962]\]           Potential participants were representative of the Nottingham Stroke Register, which includes all stroke admissions to Nottingham City Hospital and Queens Medical Centre, Nottingham, UK. ★                 No non-exposed cohort                 Patients underwent interview about shoulder pain ★       Yes ★                                     confounders were not reported.                                                                                                                                                             Questionnaire based structured interview ★   Yes ★                                                                                  84% participated at the 3-month follow-up, 61% at the 6-month follow-up, and 50% at the 12-month follow-up. ★   Poor

  Kuptniratsaikul et al. (2009) \[[@B31-ijerph-17-04962]\]   Participants were representative of Thai Stroke Rehabilitation Registry, which maintain the record of patients with stroke who underwent rehabilitation\                                                    Yes ★                                 Patients underwent interview about shoulder pain ★       No                                        Confounders were compared using the multivariate analysis. ★                                                                                                                               Questionnaire based structured interview ★   No                                                                                     No statement                                                                                                    Poor
                                                             in Thailand. ★                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Blennerhassett et al. (2010) \[[@B11-ijerph-17-04962]\]    The 94 retrospective histories of patients admitted for inpatient rehabilitation were audited which represented 63% of stroke patients in a 3-year period.                                                  Yes ★                                 Medical report                                           No                                        Confounders were compared using the logistic regression analysis. ★                                                                                                                        Retrospective data                           No                                                                                     No statement                                                                                                    Poor

  Klit et al. (2011) \[[@B32-ijerph-17-04962]\]              Participants were representative of National Indicator Project database which records all hospitalized acute stroke patients in Denmark. ★                                                                  Yes ★                                 Patients reported shoulder pain                          Yes ★                                     Confounders were compared using the multiple logistic regression analysis. ★                                                                                                               Questionnaire-based survey                   No                                                                                     No statement                                                                                                    Poor

  Hansen et al. (2012) \[[@B33-ijerph-17-04962]\]            Consecutive cohort of stroke patients admitted to a single hospital.                                                                                                                                        No                                    Patients underwent a structured interview. ★             No                                        Age and gender were adjusted in chi-square test. ★                                                                                                                                         Questionnaire based structured interview ★   Yes ★                                                                                  97% participated at the 3-month follow-up, and 92% at the 6-month follow-up. ★                                  Poor

  Lindgren et al. (2012) \[[@B34-ijerph-17-04962]\]          Participants were representative of the Lund Stroke Register which covers the population of Lund-Orup, including 8 municipalities representing the local geographical area of Lund University Hospital. ★   Yes ★                                 Patients underwent interview about shoulder pain ★       Yes ★                                     Univariate analyses were used to compare age, pain frequency, affected side, motor function, and passive range of abduction between patients with and without shoulder pain. ★             Questionnaire based structured interview ★   Yes ★                                                                                  79% participated at the 4-month follow-up, and 73% at the 12-month follow-up. ★                                 Good

  Kuptniratsaikul et al. (2013) \[[@B35-ijerph-17-04962]\]   Participants were representative of Thai Stroke Rehabilitation Registry, which maintain the record of patients with stroke who underwent rehabilitation in Thailand. ★                                      Yes ★                                 Patients underwent interview about shoulder pain ★       No                                        Confounders were compared using the multivariate analysis. ★                                                                                                                               Questionnaire based structured interview ★   Yes ★                                                                                  65% participated at the 12-month follow-up. ★                                                                   Good

  Chen et al. (2014) \[[@B36-ijerph-17-04962]\]              The medical records of patients consecutively admitted to a single hospital.                                                                                                                                No                                    Retrospective data                                       No                                        Confounders were compared using the Chi-square test. ★                                                                                                                                     Retrospective medical record data            No                                                                                     No statement                                                                                                    Poor

  Kim et al. (2014) \[[@B37-ijerph-17-04962]\]               Consecutive cohort of stroke patients admitted to a single hospital.                                                                                                                                        Yes ★                                 Patients underwent interview about\                      Yes ★                                     Age, gender and significant variables from the univariate analysis were included in the final multivariate logistic regression model. ★                                                    Questionnaire based structured interview ★   Yes ★                                                                                  78% participated at the 3-month follow-up, and 62% at the 6-month follow-up. ★                                  Good
                                                                                                                                                                                                                                                                                                               shoulder pain ★                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Kwon et al. (2014) \[[@B38-ijerph-17-04962]\]              Participants were representative of eight rehabilitation units situated in three different large local catchment area in the Republic of Korea. ★                                                           Yes ★                                 Patients underwent interview about shoulder pain ★       No                                        Age, sex, the Motricity Index of the upper and lower limbs, and ambulatory types were included in the multivariate logistic regression model. ★                                            Questionnaire based structured interview ★   No                                                                                     No statement                                                                                                    Poor

  Karaahmet et al. (2014) \[[@B39-ijerph-17-04962]\]         Consecutive cohort of stroke patients admitted to a single physical medicine and rehabilitation clinic.                                                                                                     Yes ★                                 Patients underwent interview about shoulder pain ★       No                                        Disease duration, neglect, sensory disturbance, spasticity, immobilization, late rehabilitation, and motor function were included in backward stepwise multinomial\                        Questionnaire based structured interview ★   Yes ★                                                                                  No statement                                                                                                    Fair
                                                                                                                                                                                                                                                                                                                                                                                                                  logistic regression analysis. ★                                                                                                                                                                                                                                                                                                                                                                                                                

  Adey-Wakeling et al. (2015) \[[@B3-ijerph-17-04962]\]      A population-based stroke incidence study conducted in a specific region of the western suburbs of Adelaide, South Australia. ★                                                                             Yes ★                                 Patients underwent interview about shoulder pain ★       No                                        logistic regression models were used to analyses different confounders. ★                                                                                                                  Questionnaire based structured interview ★   Yes ★                                                                                  78% participated at the 4-month follow-up, and 75% at the 12-month follow-up. ★                                 Good

  Paolucci et al. (2016) \[[@B40-ijerph-17-04962]\]          Consecutive cohort of stroke\                                                                                                                                                                               No                                    Patients underwent interview about\                      No                                        Age, gender, type of stroke, and severity of stroke were included in regression analysis. ★                                                                                                Questionnaire based structured interview ★   No                                                                                     No statement                                                                                                    Poor
                                                             patients admitted to at eight Italian hospitals. ★                                                                                                                                                                                                shoulder pain ★                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**†** Good quality: 3 or 4 stars (★) in selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome domain; Fair quality: 2 stars in selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome/exposure domain; Poor quality: 0 or 1 star in selection domain OR 0 stars in comparability domain OR 0 or 1 stars in outcome/exposure domain.
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###### 

Study characteristics.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                             Setting/Country                                  Sample Size                                             Targeted Population                                 Time since Stroke (Months) at Recruitment         Average Age at Recruitment                      Outcome Measurement                            Design
  ---------------------------------------------------------- ------------------------------------------------ ------------------------------------------------------- --------------------------------------------------- ------------------------------------------------- ----------------------------------------------- ---------------------------------------------- -------------------------------------------
  Langhorne et al. (2000) \[[@B14-ijerph-17-04962]\]         Multicenter hospital-based study/Scotland, UK.   *N* = 311                                               People with stroke, Hemiplegia                      up to 30 months after stroke                      76 years (interquartile range 70 to 82 years)   VAS                                            A prospective study

  Gamble et al. (2000) \[[@B29-ijerph-17-04962]\]            Hospital-based study/UK                          *N* = 123                                               Patients with a diagnosis of acute stroke           up to 6 months                                    70.6 years                                      VAS                                            A prospective study

  Gamble et al. (2002) \[[@B16-ijerph-17-04962]\]            Hospital-based study/UK                          *N* = 123                                               Patients with a diagnosis of acute stroke           up to 6 months                                    70.6 years (range 29--93)                       VAS                                            A prospective study

  Aras et al. (2004) \[[@B9-ijerph-17-04962]\]               Hospital-based study/Turkey                      *N* = 85                                                Patients with hemiplegia                            64.8 days from the onset                          58.7 years                                      Physical examination                           A prospective study

  Lindgren et al. (2007) \[[@B6-ijerph-17-04962]\]           Population-Based Study/Sweden                    *N* = 416                                               First-ever stroke patients                          up to 16 months                                   73.1 years (range 17--102 years)                VAS                                            A prospective study

  Sackley et al. (2008) \[[@B30-ijerph-17-04962]\]           Hospital-based study/UK                          *N* = 600                                               3-months post stroke                                3-months from the onset up to 12-months           76 years (range 31--98 years)                   VAS                                            A prospective study

  Kuptniratsaikul et al. (2009) \[[@B31-ijerph-17-04962]\]   Multicenter hospital-based study/Thailand        *N* = 327                                               Patients with stroke                                more than two months                              62.2 years (SD 12.1)                            Physical examination                           A prospective study

  Blennerhassett et al. (2010) \[[@B11-ijerph-17-04962]\]    Hospital-based data/Australia                    *N* = 94                                                Patients with stroke                                More than 2 months                                59 years (range 17--80 years)                   Physical examination                           Retrospective observational study

  Klit et al. (2011) \[[@B32-ijerph-17-04962]\]              Population-based study/Denmark                   *N* = 608 (stroke patients), 519 (reference subjects)   Patients with stroke                                Median days from stroke 794.5 (range 588--1099)   Median age, 72.6 years                          NRS                                            A prospective study

  Hansen et al. (2012) \[[@B33-ijerph-17-04962]\]            Hospital-based study/Denmark                     *N* = 299                                               Patients with stroke                                up to 6 months post stroke                        65.6 years (24--92 years)                       Interview                                      A prospective study

  Lindgren et al. (2012) \[[@B34-ijerph-17-04962]\]          Hospital-based study/Sweden                      *N* = 58                                                First-ever stroke patients                          up to 16 months                                   71 years                                        VAS                                            A prospective study

  Kuptniratsaikul et al. (2013) \[[@B35-ijerph-17-04962]\]   Multicenter hospital-based study/Thailand        *N* = 327                                               Patients with stroke                                12 months of onset                                62.1 years (SD 12.5 years)                      Physical examination                           A prospective study

  Chen et al. (2014) \[[@B36-ijerph-17-04962]\]              Hospital-based study/Taiwan                      *N* = 568                                               First-time stroke patients                          Not reported                                      65.7 years (SD 13.3 years)                      Medical records                                A retrospective longitudinal cohort study

  Kim et al. (2014) \[[@B37-ijerph-17-04962]\]               Hospital-based study/Korea                       *N* = 94                                                Patients with first-ever unilateral stroke lesion   up to 6 months post-stroke                        65.6 years                                      NRS                                            A prospective study

  Kwon et al. (2014) \[[@B38-ijerph-17-04962]\]              Hospital-based study/Korea                       *N* = 229                                               Patients with stroke                                More than 2 months                                59.0 years (SD 12.4)                            University of Alabama's Pain Behaviors Scale   A prospective study

  Karaahmet et al. (2014) \[[@B39-ijerph-17-04962]\]         Hospital-based study/Turkey                      *N* = 63                                                Patients with stroke                                More than 2 months                                61 years (range,\                               Physical examination                           A prospective study
                                                                                                                                                                                                                                                                            39--85 years)                                                                                  

  Adey-Wakeling et al. (2015) \[[@B3-ijerph-17-04962]\]      Population-Based Study/Australia                 *N* = 318                                               Patients with stroke                                Average 8.7 days post onset up to 12 years        72.5 years                                      VAS                                            A prospective study

  Paolucci et al. (2016) \[[@B40-ijerph-17-04962]\]          Hospital-based multicenter study/Italy           *N* = 443                                               Patients with stroke                                more than 90 days onset of stroke                 67.1 years                                      Neuropathic Pain Symptom Inventory             A prospective study
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

VAS: Visual analogue scale; NRS: Numerical rating scale.
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###### 

Incidence and prevalence of shoulder pain after stroke in the included studies.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                                      Incidence \[Proportion (95% CI)\]     Prevalence \[Proportion (95% CI)\]                         Prevalence in Defined Group
  ---------------------------------------------------------- ------------------------------------- ---------------------------------------------------------- --------------------------------------------------------
  L                                                          Incidence at admission: 9% (6--12%)   Weekly point prevalence: 6% (5--7%)                        

  Discharge to 6-month incidence: 15% (9--21%)                                                                                                                

  6-months to 18-months incidence: 11% (6--16%)                                                                                                               

  18-months to 30-months incidence: 12% (6--17%)                                                                                                              

  Gamble et al. (2000) \[[@B29-ijerph-17-04962]\]            Incidence at 2-week: 25%                                                                         

  Gamble et al. (2002) \[[@B16-ijerph-17-04962]\]            Incidence at 6-months: 40%                                                                       

  Aras et al. (2004) \[[@B9-ijerph-17-04962]\]                                                     Prevalence at admission: 63.5%                             

  Lindgren et al. (2007) \[[@B6-ijerph-17-04962]\]                                                 Prevalence at 4-months: 22%\                               Functional status independence: 37%
                                                                                                   Prevalence at 16-months: 24%                               

  Moderate dependence: 31%                                                                                                                                    

  Major dependence: 32%                                                                                                                                       

  Self-perceived ill health: 23%                                                                                                                              

  Arm motor function                                                                                                                                          

  No function: 27%                                                                                                                                            

  Reduced function: 56%                                                                                                                                       

  Normal function: 17%                                                                                                                                        

  Sensory disturbance for light touch: 31%                                                                                                                    

  Shoulder Subluxation: 41%                                                                                                                                   

  Sackley et al. (2008) \[[@B30-ijerph-17-04962]\]                                                 Overall prevalence: 52%                                    

  Prevalence at 3-months: 36%                                                                                                                                 

  Prevalence at 6-months: 42%                                                                                                                                 

  Prevalence at 12-months: 47%                                                                                                                                

  Kuptniratsaikul et al. (2009) \[[@B31-ijerph-17-04962]\]                                         Overall prevalence: 19%                                    Hemorrhagic stroke, prevalence of shoulder pain: 26.1%

  Infarction stroke, prevalence of shoulder pain: 16.2%                                                                                                       

  Blennerhassett et al. (2010) \[[@B11-ijerph-17-04962]\]    Incidence during inpatient: 11.7%     Prevalence at admission: 23%                               

  Prevalence during inpatient: 35%                                                                                                                            

  Klit et al. (2011) \[[@B32-ijerph-17-04962]\]              Two-year incidence: 15.1%                                                                        

  Hansen et al. (2012) \[[@B33-ijerph-17-04962]\]            Incident at onset: 1.5%                                                                          Shoulder pain in stroke-affected side at onset: 1.1%

  Incident at 3-months: 13.1%                                at 3-months: 10.2%                                                                               

  Incident at 6-months: 16.4%                                at 6-months:12.0%                                                                                

  Lindgren et al. (2012) \[[@B34-ijerph-17-04962]\]                                                Prevalence at 4 and 16-months: 19% and 72%, respectively   

  Kuptniratsaikul et al. (2013) \[[@B35-ijerph-17-04962]\]                                         Prevalence at 12-months: 8.5%                              

  Chen et al. (2014) \[[@B36-ijerph-17-04962]\]              Incidence in acute ward: 2.6%                                                                    Incidence in rehabilitation ward (age group wise)

  Incidence in rehabilitation ward:23.2%                     \< 65 years: 23.4%                                                                               

                                                             65--75 years: 22.1%                                                                              

                                                             ≥ 75 years: 24.5%                                                                                

  Kim et al. (2014) \[[@B37-ijerph-17-04962]\]               Not reported                          Not reported                                               Not reported

  Kwon et al. (2014) \[[@B38-ijerph-17-04962]\]                                                    Overall prevalence: 91.9%                                  Prevalence of shoulder pain based on ambulatory mode

  Independent: 93.3%                                                                                                                                          

  Cane: 89.2%                                                                                                                                                 

  Wheelchair: 70%                                                                                                                                             

  Karaahmet et al. (2014) \[[@B39-ijerph-17-04962]\]                                               Prevalence at admission: 53%\                              Prevalence of HSP with other complications
                                                                                                   Prevalence at discharge: 62%                               

  Neglect: 90%                                                                                                                                                

  Aphasia: 55.6%                                                                                                                                              

  Depression: 65%                                                                                                                                             

  Spasticity: 78.9%                                                                                                                                           

  Sensory disturbance: 40%                                                                                                                                    

  Subluxation: 77.8%                                                                                                                                          

  Adey-Wakeling et al. (2015) \[[@B3-ijerph-17-04962]\]      Incidence at admission: 10%\                                                                     Female: 46%
                                                             Incidence at 4 months: 21%\                                                                      
                                                             Incidence at 12 months: 21%\                                                                     
                                                             Overall incidence: 29%                                                                           

  Medical history                                                                                                                                             

  Previous stroke:12%                                                                                                                                         

  Previous MI: 17%                                                                                                                                            

  Hypertension: 71%                                                                                                                                           

  Diabetes: 28%                                                                                                                                               

  History of shoulder pain: 27%                                                                                                                               

  Stroke subtype                                                                                                                                              

  Total ischemic: 88%                                                                                                                                         

  Large artery: 14%                                                                                                                                           

  Cardio embolic: 34%                                                                                                                                         

  Lacunar: 9%                                                                                                                                                 

  Other/unknown ischemic: 32%                                                                                                                                 

  Hemorrhagic: 9%                                                                                                                                             

  Unknown: 2%                                                                                                                                                 

  Left side: 52%                                                                                                                                              

  High NIHSS score (\> median): 5%                                                                                                                            

  Motor arm                                                                                                                                                   

  Reduced function: 38%                                                                                                                                       

  No function: 31%                                                                                                                                            

  Paolucci et al. (2016) \[[@B40-ijerph-17-04962]\]                                                Overall mean prevalence: 9.41%                             

  Acute phase prevalence: 0.63%                                                                                                                               

  Sub-acute phase prevalence: 17.27%                                                                                                                          

  Chronic phase prevalence:10.34%                                                                                                                             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Shoulder pain and risk factors used in the included studies.

  Study                                                     Risk Factors of Shoulder Pain Which Were Assessed   Odd Ratios (OR) \[95% Confidence Interval (CI)\]
  --------------------------------------------------------- --------------------------------------------------- --------------------------------------------------
  Blennerhassett et al. (2010) \[[@B11-ijerph-17-04962]\]   Gender (male)                                       0.89 (0.36 to 2.16)
  Altered Tone                                              18.94 (6.46 to 55.51)                               
  Subluxation                                               19.34 (5.57 to 65.94)                               
  Sensory deficits                                          2.59 (1.08 to 6.17)                                 
  Inattention/neglect                                       1.53 (0.59 to 3.97)                                 
  Cognitive impairment                                      1.03 (0.44 to 2.40)                                 
  Impaired communication                                    1.48 (0.62 to 3.50)                                 
  Type of stroke                                            0.76 (0.26 to 2.17)                                 
  Hand dominance                                            0.24 (0.03 to 2.05)                                 
  Previous shoulder problem                                 2.55 (0.63 to 10.22)                                
  Klit et al. (2011) \[[@B32-ijerph-17-04962]\]             Males (vs. females)                                 0.77 (0.53--1.11)
  Age 65--74 years (vs. \< 65 years)                        0.57 (0.36--0.90)                                   
  Age \> 75 years (vs. \< 65 years)                         0.65 (0.43--0.99)                                   
  Diabetes (vs. no diabetes)                                1.08 (0.65--1.78)                                   
  Depression (vs. no depression)                            3.43 (2.25--5.25)                                   
  Infarction (vs. hemorrhage)                               0.73 (0.43--1.26)                                   
  Unspecified (vs. hemorrhage)                              1.09 (0.57--2.09)                                   
  Lindgren et al. (2012) \[[@B34-ijerph-17-04962]\]         Left-sided hemiparesis                              10.47 (1.92--57.05), *p* = 0.01
  Pain frequency                                            6.85 (1.46--32.14), *p* = 0.02                      
  Decreased passive abduction                               4.46 (0.99--20.10), *p* = 0.05                      
  Age                                                       1.05 (0.99--1.12), *p* = 0.07                       
  Kim et al. (2014) \[[@B37-ijerph-17-04962]\]              Young age (\< 70 years)                             3.65 (1.250--10.637), *p* = 0.018
  Male                                                      0.99 (0.370--2.683), *p* = 0.99                     
  Poor NIHSS item 5 score (≥ 3)                             2.96 (1.141--7.665), *p* = 0.026                    
  Presence of long head of biceps                           2.35 (0.897--6.150), *p* = 0.082                    
  tendon effusion                                                                                               
  Presence of supraspinatus tendon                          4.21 (1.372--12.931), *p* = 0.012                   
  tendinosis/tear                                                                                               
  Karaahmet et al. (2014) \[[@B39-ijerph-17-04962]\]        Neglect                                             7.20 (0.840--61.4690), *p* = 0.071
  Sensory disturbance                                       3.26 (0.478--22.301), *p* = 0.228                   
  Spasticity                                                1.56 (0.272--9.002), *p* = 0.617                    
  Immobilization                                            3.28 (0.527--20.457), *p* = 0.203                   
  Late rehabilitation                                       0.52 (0.025--10.658), *p* = 0.669                   
  Disease duration                                          1.05 (0.964--1.134), *p* = 0.279                    
  Baseline FMA (Fugl-Meyer Motor Assessment.)               0.99 (0.905--1.083), *p* = 0.822                    
  Baseline FAT (Frenchay Arm Test)                                                                              
  Baseline FIM (Functional Independence Measure)            0.66 (0.234--1.872), *p* = 0.437                    
                                                            1.01 (0.970--1.045), *p* = 0.720                    
  Adey-Wakeling et al. (2015) \[[@B3-ijerph-17-04962]\]     Mean age (y)                                        0.96 (0.79--1.17), *p* = 0.690
  Sex: female                                               1.03 (0.77--1.37), *p* = 0.845                      
  *Medical history*                                                                                             
  Previous stroke                                           0.47 (0.21--1.07), *p* = 0.074                      
  Previous MI                                               1.16 (0.53--2.54), *p* = 0.705                      
  Hypertension                                              0.96 (0.50--1.85), *p* = 0.907                      
  Diabetes                                                  1.20 (0.62--2.30), *p* = 0.587                      
  History of shoulder pain                                  8.09 (3.16--20.75), *p* = \< 0.0001                 
  *Stroke subtype*                                                                                              
  Cardioembolic                                             1.10 (0.60--2.01), *p* = 0.767                      
  Lacunar                                                   0.85 (0.36--2.04), *p* = 0.719                      
  Other/unknown ischemic                                    1.45 (0.78--2.72), *p* = 0.241                      
  Hemorrhagic                                               1.22 (0.49--3.01), *p* = 0.670                      
  Unknown                                                   0.57 (0.09--3.47), *p* = 0.541                      
  Right Hemiparesis                                         0.87(0.65--1.17), *p* = 0.350                       
  High NIHSS score (\> median)                              1.39 (0.78--2.49), *p* = 0.268                      
  *Motor arm*                                                                                                   
  Reduced function                                          1.20 (0.79--1.83), *p* = 0.399                      
  No function                                               1.91 (1.20--3.04), *p* = 0.007                      
